Assenagon Asset Management S.A. Raises Position in Option Care Health, Inc. (NASDAQ:OPCH)

Assenagon Asset Management S.A. boosted its holdings in Option Care Health, Inc. (NASDAQ:OPCH) by 128.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 292,090 shares of the company’s stock after purchasing an additional 164,086 shares during the period. Assenagon Asset Management S.A. owned approximately 0.17% of Option Care Health worth $6,776,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in the business. Federated Hermes Inc. boosted its stake in shares of Option Care Health by 5.5% during the second quarter. Federated Hermes Inc. now owns 20,621 shares of the company’s stock valued at $571,000 after purchasing an additional 1,073 shares during the period. Envestnet Asset Management Inc. boosted its position in Option Care Health by 2.8% during the 2nd quarter. Envestnet Asset Management Inc. now owns 231,315 shares of the company’s stock valued at $6,407,000 after buying an additional 6,283 shares during the period. Dimensional Fund Advisors LP grew its holdings in Option Care Health by 6.5% in the 2nd quarter. Dimensional Fund Advisors LP now owns 3,605,271 shares of the company’s stock worth $99,870,000 after acquiring an additional 218,844 shares during the last quarter. XTX Topco Ltd purchased a new position in shares of Option Care Health in the second quarter valued at about $973,000. Finally, Intech Investment Management LLC bought a new position in shares of Option Care Health during the second quarter valued at about $1,014,000. 98.05% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of research analysts recently issued reports on the company. Truist Financial reduced their price target on Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a report on Friday, November 1st. Barrington Research upped their target price on Option Care Health from $32.00 to $33.00 and gave the company an “outperform” rating in a report on Tuesday, January 14th. Bank of America raised shares of Option Care Health from a “neutral” rating to a “buy” rating and boosted their price objective for the company from $26.00 to $33.00 in a research report on Monday, January 13th. Jefferies Financial Group cut shares of Option Care Health from a “buy” rating to a “hold” rating and dropped their target price for the stock from $38.00 to $26.00 in a research report on Thursday, October 31st. Finally, UBS Group initiated coverage on shares of Option Care Health in a research report on Thursday, December 5th. They set a “neutral” rating and a $26.00 price target on the stock. Three equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $29.86.

Insider Buying and Selling at Option Care Health

In other news, Director Harry M. Jansen Kraemer, Jr. purchased 43,000 shares of Option Care Health stock in a transaction that occurred on Friday, November 8th. The stock was bought at an average price of $22.54 per share, with a total value of $969,220.00. Following the completion of the transaction, the director now directly owns 326,334 shares of the company’s stock, valued at approximately $7,355,568.36. The trade was a 15.18 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.64% of the stock is owned by company insiders.

Option Care Health Stock Down 0.5 %

NASDAQ:OPCH opened at $29.16 on Monday. Option Care Health, Inc. has a 1-year low of $21.39 and a 1-year high of $34.63. The company has a market capitalization of $4.96 billion, a PE ratio of 24.50, a P/E/G ratio of 2.44 and a beta of 1.31. The firm’s 50-day moving average price is $23.70 and its 200-day moving average price is $27.73. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.